Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1977 Mar 12;1(6062):679–682. doi: 10.1136/bmj.1.6062.679

Somatomedin in growth disorders and chronic renal insufficiency in children.

S L Schwalbe, P R Betts, P H Rayner, B T Rudd
PMCID: PMC1605511  PMID: 843868

Abstract

Somatomedin activity was measured using an embryonic chick cartilage assay in 33 normal and short normal children, 23 children with pituitary growth hormone (GH) deficiency, 14 children with sexual precocity, and 13 children with chronic renal insufficiency. In normal children somatomedin activity correlated well with chronological age: low valles in early childhood rose to higher than adult levels at puberty. Children with GH deficiency had significantly lower activities and those with sexual precocity significantly higher activities than normal children. In all three groups somatomedin activity correlated well with bone age. In children with chornic renal insufficiency there was a significant correlation between decreasing somatomedin activity and both a reduced growth velocity and a falling glomerular filtration rate. Somatomedin activity and growth velocity were within normal limits in children with glomerular filtration rates above 30 ml/min/1-73 m2.

Full text

PDF
679

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Audhya T. K., Gibson K. D. Serum inorganic sulfate and apparent somatomedin activity in an assay using chick embryo cartilage. Endocrinology. 1974 Dec;95(6):1614–1620. doi: 10.1210/endo-95-6-1614. [DOI] [PubMed] [Google Scholar]
  2. Betts P. R., Magrath G. Growth pattern and dietary intake of children with chronic renal insufficiency. Br Med J. 1974 Apr 27;2(5912):189–193. doi: 10.1136/bmj.2.5912.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Chantler C., Barratt T. M. Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid. Arch Dis Child. 1972 Aug;47(254):613–617. doi: 10.1136/adc.47.254.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Daughaday W. H., Hall K., Raben M. S., Salmon W. D., Jr, van den Brande J. L., van Wyk J. J. Somatomedin: proposed designation for sulphation factor. Nature. 1972 Jan 14;235(5333):107–107. doi: 10.1038/235107a0. [DOI] [PubMed] [Google Scholar]
  5. Elders M. J., Wingfield B. S., McNatt M. L., Clarke J. S., Hughes E. R. Glucocorticoid therapy in children. Effect on somatomedin secretion. Am J Dis Child. 1975 Dec;129(12):1393–1396. doi: 10.1001/archpedi.1975.02120490011005. [DOI] [PubMed] [Google Scholar]
  6. Frasier S. D., Hilburn J. M., Smith F. G. Effect of adolescence on the serum growth hormone response to hypoglycemia. J Pediatr. 1970 Sep;77(3):465–467. doi: 10.1016/s0022-3476(70)80019-1. [DOI] [PubMed] [Google Scholar]
  7. Glasgow E. F., Moncrieff M. W., White R. H. Symptomless haematuria in childhood. Br Med J. 1970 Jun 20;2(5711):687–692. doi: 10.1136/bmj.2.5711.687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Grant D. B., Hambley J., Becker D., Pimstone B. L. Reduced sulphation factor in undernourished children. Arch Dis Child. 1973 Aug;48(8):596–600. doi: 10.1136/adc.48.8.596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HARTOG M., GAAFAR M. A., MEISSER B., FRASER R. IMMUNOASSAY OF SERUM GROWTH HORMONE IN ACROMEGALIC PATIENTS. Br Med J. 1964 Nov 14;2(5419):1229–1232. doi: 10.1136/bmj.2.5419.1229. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hall K., Filipsson R. Correlation between somatomedin A in serum and body height development in healthy children and children with certain growth disturbances. Acta Endocrinol (Copenh) 1975 Feb;78(2):239–250. doi: 10.1530/acta.0.0780239. [DOI] [PubMed] [Google Scholar]
  11. Hall K. Quantative determination of the sulphation factor activity in human serum. Acta Endocrinol (Copenh) 1970 Feb;63(2):338–350. doi: 10.1530/acta.0.0630338. [DOI] [PubMed] [Google Scholar]
  12. KOGUT M. D., KAPLAN S. A., SHIMIZU C. S. Growth retardation: use of sulfation factor as a bioassay for growth hormone. Pediatrics. 1963 Apr;31:538–551. [PubMed] [Google Scholar]
  13. ROTH J., GLICK S. M., YALOW R. S., BERSON S. A. Secretion of human growth hormone: physiologic and experimental modification. Metabolism. 1963 Jul;12:577–579. [PubMed] [Google Scholar]
  14. SALMON W. D., Jr, DAUGHADAY W. H. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. J Lab Clin Med. 1957 Jun;49(6):825–836. [PubMed] [Google Scholar]
  15. Saenger P., Wiedemann E., Schwartz E., Korth-Schutz S., Lewy J. E., Riggio R. R., Rubin A. L., Stenzel K. H., New M. I. Somatomedin and growth after renal transplantation. Pediatr Res. 1974 Mar;8(3):163–169. doi: 10.1203/00006450-197403000-00003. [DOI] [PubMed] [Google Scholar]
  16. Tanner J. M., Whitehouse R. H., Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. Arch Dis Child. 1966 Oct;41(219):454–471. doi: 10.1136/adc.41.219.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. van den Brande J. L., Du Caju M. V. An improved technique for measuring somatomedin activity in vitro. Acta Endocrinol (Copenh) 1974 Feb;75(2):233–242. doi: 10.1530/acta.0.0750233. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES